|
Cannabis Campaigners' Guide News Database result:
|
|
UK: British Company To Test Cannabis For Cancer Pain Stephen Cunningham Reuters Saturday 19 Jan 2002 GW Pharmaceuticals, which has a government license to grow cannabis, said Wednesday it was expanding clinical trials to ease the pain of cancer patients. Trials involving patients with multiple sclerosis and spinal cord injury had already proved successful, it said. While cannabis use is illegal, many people in the UK suffering from serious diseases have been lobbying for its use for medicinal purposes. GW said more than 100 patients with terminal cancer who are suffering pain that is not responding to current therapy will take part in trials at more than 20 centers throughout the country. Patients will not actually smoke the drug, but instead will use an under-the-tongue spray. Executive Chairman Geoffrey Guy said this represented a key milestone for GW since "cannabis-based medicine has the potential to provide considerable advantages over current medications to cancer patients." Around 40% of cancer patients could benefit if the trials were successful, he added. Guy said GW was on course to become the first company in the world to win regulatory approval for prescription cannabis-based medicines. "We remain confident of being able to present data to the UK regulatory authorities in 2003, and--subject to approval--bring the first cannabis-based prescription medicine to market in early 2004," Guy said.
After you have finished reading this article you can click here to go back.
|
This page was created by the Cannabis Campaigners' Guide.
Feel free to link to this page!